RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
基本信息
- 批准号:6188328
- 负责人:
- 金额:$ 18.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-07-01 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS /HIV neuropathy AIDS dementia complex Lentivirus cell cycle cell line cerebellum cytokine receptors disease /disorder model fluorescent dye /probe gene expression human immunodeficiency virus 1 human tissue immunocytochemistry laboratory mouse latent virus infection leukocyte activation /transformation microglia mixed tissue /cell culture neural cell adhesion molecules phenotype postmortem provirus sheep tissue /cell culture virus infection mechanism
项目摘要
DESCRIPTION (adapted from applicant's abstract): Neuronal injury and microglial
activation are related processes that appear central to a number of chronic
neurodegenerative diseases including AIDS dementia. Ramified tissue microglia
are highly branched, quiescent cells that secrete neurotrophic factors.
Generally, neuronal damage can be an important early trigger in activating
ramified tissue microglia to become phagocytic macrophage-like cells.
Uncontrolled activation of microglia results in release of a variety of
substances that are toxic to bystander neurons. Conversely, healthy neurons and
certain soluble factors oppose microglia activation by signaling microglia to
maintain a quiescent, ramified phenotype, downregulate production of neurotoxic
substances, and upregulate production of neurotrophic factors. Fine regulation
of this reversible microglial activation/ramification cycle limits neuronal
injury during infection or insult and favors regenerative healing following
injury to the CNS.
Clearance of cellular reservoirs that harbor HIV during HAART treatment is
mainly dependent on the particular turnover rate of the reservoir target cell
population. Most of the HIV-1-infected cells in the brain are macrophages and
microglia. Ramified tissue microglia in the CNS represent one of the most
stable cell types in the body and have one of the slowest turnover rates of any
HIV target cell population that has been measured. Virus could persist in these
quiescent cells for years or perhaps even decades before the cells turn over.
However, since poorly characterized cellular interactions and unknown soluble
factors mediate and maintain microglial ramification in the brain and because
they are inaccessible, ramified microglia remain poorly understood. The
investigators have developed neuron-rich organotypic brain slice cultures and
dissociated cortical brain cultures that support microglial ramification and
visna lentivirus infection in vitro. This type of system offers a unique
opportunity to investigate the biology of the lentivirus-infected ramified
microglia in neuron-rich, simulated brain microenvironments conducive to
experimental manipulation and mechanistic studies. Such model systems could
provide important insights into HIV persistence in the CNS.
The central hypothesis is that HIV-infected cells in the brain include ramified
tissue microglia with latent or restricted infection. Replication competent
provirus persists in this cellular reservoir for prolonged periods in spite of
treatment due to the extremely slow turnover rate of these cells and its
location behind the blood brain barrier. We will test these hypotheses by: 1)
improving and characterizing primary culture models of microglial ramification,
2) determining the effect of lentivirus infection microglial ramification, 3)
identifying changes in susceptibility to lentivirus infection that occur during
microglial ramification, and 4) characterizing markers and modulators of
ramification of infected and uninfected microglia.
描述(改编自申请人摘要):神经元损伤和小胶质细胞
激活是相关的过程,似乎是许多慢性疾病的核心。
神经退行性疾病,包括艾滋病痴呆症。分支组织小胶质细胞
是高度分支的静止细胞,分泌神经营养因子。
一般来说,神经元损伤可能是激活的重要早期触发因素,
分支组织小胶质细胞成为吞噬巨噬细胞样细胞。
小胶质细胞的不受控制的激活导致释放多种
对旁观者神经元有毒的物质。相反,健康的神经元和
某些可溶性因子通过向小胶质细胞发出信号来对抗小胶质细胞活化,
维持静止的分枝表型,下调神经毒素的产生
物质,并上调神经营养因子的产生。精细调节
这种可逆的小胶质细胞激活/分支循环限制了神经元的
在感染或损伤期间的损伤,并有利于再生愈合后,
损伤CNS。
在HAART治疗过程中清除携带HIV的细胞库,
主要取决于储库靶细胞的特定周转率
人口大脑中大多数感染HIV-1的细胞是巨噬细胞,
小胶质细胞中枢神经系统中的分支组织小胶质细胞代表了中枢神经系统中
稳定的细胞类型在体内,并有一个最慢的周转率的任何
已测量的HIV靶细胞群。病毒可以在这些
静止细胞数年甚至数十年,然后细胞才开始转变。
然而,由于细胞间相互作用的特征不明显,
因子介导和维持大脑中的小胶质细胞分支,
它们是不可接近的,分支的小胶质细胞仍然知之甚少。的
研究者已经开发出富含神经元的器官型脑切片培养物,
支持小胶质细胞分支的分离的皮质脑培养物,
visna慢病毒体外感染。这种类型的系统提供了一个独特的
有机会研究慢病毒感染的分枝
在富含神经元的模拟大脑微环境中的小胶质细胞,
实验操作和机械研究。这种模型系统可以
提供了重要的见解艾滋病毒在中枢神经系统的持久性。
核心假设是,大脑中感染艾滋病毒的细胞包括分支的
组织小胶质细胞具有潜伏性或限制性感染。复制能力的
前病毒在细胞中存留很长时间,
由于这些细胞的周转速度非常慢,
位于血脑屏障后面。我们将通过以下方式检验这些假设:1)
改进和表征小胶质细胞衍生物的原代培养模型,
2)确定慢病毒感染小胶质细胞衍生物的影响,3)
确定在慢病毒感染期间发生的对慢病毒感染的易感性的变化,
小胶质细胞衍生物,和4)表征小胶质细胞衍生物的标记物和调节剂,
感染和未感染的小胶质细胞的分支。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID L HUSO其他文献
DAVID L HUSO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID L HUSO', 18)}}的其他基金
MENTORING IN MOUSE MOLECULAR PATHOBIOLOGY RESEARCH
小鼠分子病理学研究的指导
- 批准号:
6285897 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
- 批准号:
6639835 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
- 批准号:
6895607 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
- 批准号:
6747715 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
Mentoring in Mouse Molecular Pathobiology Research
小鼠分子病理学研究的指导
- 批准号:
6540556 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
- 批准号:
6394248 - 财政年份:1999
- 资助金额:
$ 18.83万 - 项目类别:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
- 批准号:
6540175 - 财政年份:1999
- 资助金额:
$ 18.83万 - 项目类别:
RAMIFIED MICROGLIA AND LENTIVIRUS PERSISTENCE
分支小胶质细胞和慢病毒的持久性
- 批准号:
6019902 - 财政年份:1999
- 资助金额:
$ 18.83万 - 项目类别:
NEURONAL DAMAGE RESULTING FROM LENTIVIRAL INFECTION
慢病毒感染引起的神经元损伤
- 批准号:
2655545 - 财政年份:1996
- 资助金额:
$ 18.83万 - 项目类别:
相似海外基金
The kynurenine pathway chemokines and MIC-1 in the pathogenesis of AIDS dementia complex.
犬尿氨酸途径趋化因子和 MIC-1 在艾滋病痴呆复合体发病机制中的作用
- 批准号:
nhmrc : 209548 - 财政年份:2002
- 资助金额:
$ 18.83万 - 项目类别:
NHMRC Project Grants
MRS OF PATS W/ AIDS DEMENTIA COMPLEX: MULTICENTER ACTG 301 DRUG EVAL PROGRAM
患有艾滋病痴呆症的 PATS 夫人:多中心 ACTG 301 药物评估计划
- 批准号:
6657668 - 财政年份:2002
- 资助金额:
$ 18.83万 - 项目类别:
ACTG 301 TRIAL OF MEMANTINE FOR AIDS DEMENTIA COMPLEX (ADC)
ACTG 301 美金刚治疗艾滋病痴呆症 (ADC) 的试验
- 批准号:
6571869 - 财政年份:2002
- 资助金额:
$ 18.83万 - 项目类别:
NEUROLOGICAL EVALUATION OF THE AIDS DEMENTIA COMPLEX IN ACTG CLINICAL TRIALS
ACTG 临床试验中艾滋病痴呆症的神经学评估
- 批准号:
6445211 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
MRS OF PATS W/ AIDS DEMENTIA COMPLEX: MULTICENTER ACTG 301 DRUG EVAL PROGRAM
患有艾滋病痴呆症的 PATS 夫人:多中心 ACTG 301 药物评估计划
- 批准号:
6495477 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
ACTG 301--MEMANTINE FOR AIDS DEMENTIA COMPLEX WITH ANTIRETROVIRAL THERAPY
ACTG 301--美金刚联合抗逆转录病毒疗法治疗艾滋病痴呆症
- 批准号:
6565844 - 财政年份:2001
- 资助金额:
$ 18.83万 - 项目类别:
NEUROLOGICAL EVALUATION OF THE AIDS DEMENTIA COMPLEX IN ACTG CLINICAL TRIALS
ACTG 临床试验中艾滋病痴呆症的神经学评估
- 批准号:
6302834 - 财政年份:2000
- 资助金额:
$ 18.83万 - 项目类别:
ACTG 301--MEMANTINE FOR AIDS DEMENTIA COMPLEX WITH ANTIRETROVIRAL THERAPY
ACTG 301--美金刚联合抗逆转录病毒疗法治疗艾滋病痴呆症
- 批准号:
6468094 - 财政年份:2000
- 资助金额:
$ 18.83万 - 项目类别:
MRS OF PATS W/ AIDS DEMENTIA COMPLEX: MULTICENTER ACTG 301 DRUG EVAL PROGRAM
患有艾滋病痴呆症的 PATS 夫人:多中心 ACTG 301 药物评估计划
- 批准号:
6349334 - 财政年份:2000
- 资助金额:
$ 18.83万 - 项目类别:
ROLE OF KUNURENINE PATHWAY METABOLITES IN THE PATHOGEN-ESIS OF THE AIDS DEMENTIA COMPLEX
昆仑氨酸途径代谢物在艾滋病痴呆症发病中的作用
- 批准号:
nhmrc : 7484 - 财政年份:2000
- 资助金额:
$ 18.83万 - 项目类别:
CARG - People